Atrium Therapeutics, Inc. · NASDAQ:RNA

Atrium Therapeutics, Inc. shareholders

As of Sep 30, 2026, 144 institutions reported holding Atrium Therapeutics, Inc., 82.1% of its shares. Largest: Sessa Capital IM, L.P., BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Atrium Therapeutics, Inc.ChangeFiled
Sessa Capital IM, L.P.1.5M8.8%no changeNov 16, 2026
BlackRock1.22M7.1%−229KNov 13, 2026
Vanguard949K5.5%+1,232Nov 13, 2026
T. Rowe Price640K3.7%−833KNov 16, 2026
O'Connor Alternative Investments, LLC559K3.3%newNov 16, 2026
Bracebridge Capital, LLC524K3.1%+385KNov 16, 2026
TIG Advisors, LLC507K3.0%−54,607Nov 16, 2026
Bank of America468K2.7%+335KNov 16, 2026
Two Sigma427K2.5%+81,903Nov 16, 2026
Geode Capital380K2.2%−7,113Nov 6, 2026

Atrium Therapeutics, Inc. insider trades